Pharmacological basis for the medicinal use of cardamom in asthma

Authors

  • Arif ullah Khan Natural Product Research Division, Department of Biological and Biomedical Sciences, Aga Khan University Medical College, Karachi-74800, Pakistan; Institute of Pharmaceutical Sciences, Kohat University of Science and Technology, Kohat 26000
  • Qaiser Jabeen Khan Natural Product Research Division, Department of Biological and Biomedical Sciences, Aga Khan University Medical College, Karachi-74800, Pakistan; Faculty of Pharmacy and Alternative Medicine, The Islamia University of Bahawalpur, 63100
  • Anwar Hassan Gilani Natural Product Research Division, Department of Biological and Biomedical Sciences, Aga Khan University Medical College, Karachi 74800

DOI:

https://doi.org/10.3329/bjp.v6i1.8133

Keywords:

Cardamom, Bronchodilation, Ca channel blocker, Asthma

Abstract

Cardamom (Elettaria cardamomum) is widely used in folk medicine for the treatment of asthma. This study describes its airways relaxant potential, with elucidation of possible underlying mechanism. Crude extract of cardamom which tested positive for alkaloids, flavonoids, saponins, sterols and tannins, when tested against carbachol-mediated bronchoconstriction in rats under anesthesia, it dose-dependently (10-100 mg/kg) suppressed the carbachol (1 µmol/kg)-evoked increase in the inspiratory pressure. In isolated rabbit trachea tissues, crude extract of cardamom caused relaxation of both carbachol (1 µM) and high K+ (80 mM)-induced contractions, like that caused by verapamil, suggesting its Ca++ channel blockade action. These results indicate that cardamom exhibits bronchodilatory effect, mediated through Ca++ antagonist mechanism, which provides sound mechanistic background for its medicinal use in asthma.

Downloads

Download data is not yet available.
Abstract
1229
Download
766 Read
2

References

Barnes PJ. Drugs for asthma. Br J Pharmacol. 2006; 147: S297-S303.

Duke JA. Handbook of phytochemical constituents of GRAS herbs and other economical plants. London, CRC Press, 1992, pp 239-40.

Duke JA, Bogenschutz-Godwin MJ, DuCelliar J, Duke PK. Hand book of medicinal herbs. 2nd ed. Boca Raton, CRC Press, 2002, pp 153-54.

Fleckenstein A. Specific pharmacology of Ca++ in cardiac pacemakers and vascular smooth muscle. Rev Pharmacol Toxicol. 1977; 17: 149-66.

Ghayur MN, Khan H, Gilani AH. Antispasmodic, bronchodilator and vasodilator activites of (+)-catechin, a naturally occurring flavonoid. Arch Pharm Res. 2007; 30: 970-75.

Gilani AH, Bashir S, Khan A. Pharmacological basis for the use of Borago officinalis in gastrointestinal, respiratory and cardiovascular disorders. J Ethnopharmacol. 2007; 114: 393-99.

Gilani SN, Khan A, Gilani AH. Pharmacological basis for the medicinal use of Zanthoxylum armatum in gut, airways and cardiovascular disorders. Phytother Res. 2010; 24: 553-58.

Godfraind T, Miller R, Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev. 1986; 38: 321-416.

Gopalakrishnan M, Narayanan CS, Grenz M. Non saponifiable lipid constituents of cardamom. J Agr Food Chem. 1990; 38: 2133-36.

Kapoor LD. Handbook of Ayurvedic medicinal plants. CRC Press, Boca Raton, 1990, p 172.

Khan A, Gilani AH. Antidiarrheal, antisecretory and bronchodilatory activities of Hypericum perforatum. Pharm Biol. 2009; 47: 962-67.

Nadkarni KM. Indian materia medica. 3rd ed. Bombay, Popular Prakashan, 1976, pp 475-76.

National Research Council. Guide for the care and use of laboratory animals. Washington, National Academy Press, 1996, pp 1-7.

Twiss MA, Harman E, Chesrown S, Handeles L. Efficacy of calcium channel blockers as maintenance therapy for asthma. Br J Clin Pharmacol. 2002; 53: 243-49.

Downloads

Additional Files

Published

2011-08-03

How to Cite

Khan, A. ullah, Q. J. Khan, and A. H. Gilani. “Pharmacological Basis for the Medicinal Use of Cardamom in Asthma”. Bangladesh Journal of Pharmacology, vol. 6, no. 1, Aug. 2011, pp. 34-37, doi:10.3329/bjp.v6i1.8133.

Issue

Vol. 6 No. 1 (2011)

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).